Meeting
2024 ASCO Breakthrough
Multimodal analysis of methylation and fragmentomic profiles in plasma cell free DNA for differentiation of benign and malignant breast tumors.
Authors
Thi Tuong Vi Van
Medical Genetics Institute, Ho Chi Minh City, Viet Nam
Thi Tuong Vi Van , Hanh Thi-Hue Nguyen , Thien-Chi Van Van Nguyen , Dac Ho Vo , Trung Hieu Tran , Trong Hieu Nguyen , Nhu Nhat Tan Doan , Le Anh Khoa Huynh , Xuan Vinh Nguyen , Hoa Giang , Minh-Duy Phan , Hoai Nghia Nguyen , Le Son Tran
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Thoracic Cancers,Breast Cancer,Gynecologic Cancer,Head and Neck Cancer,Hematologic Malignancies,Genetics/Genomics/Multiomics,Healthtech Innovations,Models of Care and Care Delivery,Viral-Mediated Malignancies,Other Malignancies or Topics
Sub Track
Diagnostics
Citation
J Clin Oncol 42, 2024 (suppl 23; abstr 7)
DOI
10.1200/JCO.2024.42.23_suppl.7
Abstract #
7
Poster Bd #
A6
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Trends in breast cancer mortality according to molecular subtypes: A population-based study.
First Author: Yunan Han
First Author: Antonella Ferro
Poster
2023 ASCO Annual Meeting
Genomic characterization of the GATA3 mutational landscape in breast cancer.
First Author: Jason A Mouabbi
Poster
2018 ASCO Annual Meeting
Long-term benefit from tamoxifen therapy for patients with Luminal A and Luminal B breast cancer: Retrospective analysis of the STO-3 trial.
First Author: Linda Lindström